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Tissue engineering the kidney. The means by which kidney and function [1]. In order for glomerular filtration, reab-
function can be replaced in humans include dialysis and renal sorption, and secretion of fluid and electrolytes to take
allotransplantation. Dialytic therapies are lifesaving, but often place in a manner that will sustain life, the nephrons mustpoorly tolerated. Transplantation of human kidneys is limited
be integrated in three dimensions with one another andby the availability of donor organs. During the past decades,
with a collecting system, the origin of which is yet anothera number of different approaches have been applied toward
tissue engineering the kidney as a means to replace renal func- separate structure, the ureteric bud [2], and vasculariza-
tion. The goals of one or another of them included the recapitu- tion must occur in a unique organ-specific manner from
lation of renal filtration, reabsorptive and secretory functions, endothelial precursors that may originate from both in-and replacement of endocrine/metabolic activities. This review
side and outside of the developing renal anlage [3–5].will delineate the progress to date recorded for five approaches:
In addition to its filtration reabsorptive and secretory(1) integration of new nephrons into the kidney; (2) growing
new kidneys in situ; (3) use of stem cells; (4) generation of functions, the kidney is an endocrine/metabolic organ.
histocompatible tissues using nuclear transplantation; and (5) It is a major site of erythropoetin [6], and renin [7] synthe-
bioengineering of an artificial kidney. All five approaches uti- sis, 1- hydroxylation of 25(OH)D3 [8], and 5 deiodina-lize cellular therapy. The first four employ transplantation as
tion of thyroid hormone [9]. In an ideal tissue-engineeredwell, and the fifth uses dialysis.
kidney, these functions will be recapitulated.
During the past decades, a number of different ap-
proaches have been applied toward tissue engineering aA major goal of tissue engineering is to replace, repair,
kidney. The goals of each approach were to replace someor enhance the biologic function of damaged tissues or
if not all of the kidney functions described above. Thisorgans. In the case of the kidney, the tissue engineer has
review will summarize the progress to date recorded fora formidable task. This is because the mature kidney is
five approaches: (1) integration of new nephrons intoa remarkably complex structure, the function of which
the kidney; (2) growing new kidneys in situ; (3) use ofis dependent on the growth and differentiation of its
stem cells; (4) generation of histocompatible tissues us-precursor cells within the intermediate mesoderm (meta-
ing nuclear transplantation; and (5) bioengineering ofnephric blastema and ureteric bud) into a mature organ
an artificial kidney.consisting of many different cell types. Al Awqati and
Oliver [1] have estimated that there are at least 26 termi-
nally differentiated cell types in the kidney of a newborn APPROACHES TOWARD TISSUE
mouse that arise from at least four cell types present in ENGINEERING A KIDNEY
the undifferentiated metanephric blastema when renal
Integration of new embryonic nephrons into the kidney
development begins.
The methodology for studies directed toward integrat-Delineation of 26 terminally differentiated nephron
ing new nephrons into the kidney derives from a litera-cell types takes into account cell morphology, location,
ture describing the transplantation of renal anlagen (meta-
nephroi) derived from embryos. Metanephroi have been
1 The guest editor for this paper was Adrian Woolf, London, United transplanted successfully to a number of sites, including
Kingdom. the chorioallantoic membrane of developing birds [3],
the anterior chamber of the eye [4, 10] beneath the renalKey words: cell therapy, dialysis, kidney, metanephros, nephron, stem
cells, transplantation. capsule [10–17], into a tunnel fashioned within the renal
cortex of recipients [18, 19], and intraperitoneally [17,Received for publication November 8, 2002
20–25].and in revised form December 9, 2002
Accepted for publication December 17, 2002 Most studies that employed renal subcapsular meta-
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anterior chamber of the eye [4, 10], and onto the chorio- E15 embryos were cotransplanted at different sites into
Wistar Furth rats, metanephroi underwent a more severeallantoic membrane [3] were conducted to define the
immune response to fetal kidney transplants [11–16] or rejection than if they were implanted without liver [13].
APCs populate liver well before E15 in rats, but areto delineate the means by which renal anlagen are vascu-
larized [3, 4, 10]. However, from these studies emerged not present in the circulation until several days later [26].
It was speculated that the absence of APCs in meta-information that led to approaches designed to employ
metanephros transplantation as a means to enhance re- nephroi obtained from E15 embryos, together with their
presence in liver tissue obtained concurrently, could ex-nal function [17–19, 25].
plain the differential fate of metanephroi transplanted
The immune response to fetal kidney transplants: with or without liver. Under the former conditions, but
Antigen presentation not the latter, direct presentation of donor antigens to
host T cells could take place [13].In order that a host T-cell–mediated response directed
toward antigens from transplanted tissue can be mounted,
The immune response to fetal kidney transplants:transplant antigens must first be presented to host T cells
MHC expressionin a manner that activates the host immune system. Trans-
plant antigens can be presented by antigen-presenting It has been postulated that donor antigens such as
major histocompatibility (MHC) class I and II may notcells (APCs) originating from within the donor organ
(direct presentation) or by APCs of host origin (indirect be expressed on fetal tissue to the extent they are ex-
pressed in adults [12, 15].presentation). One theoretical advantage gained through
the use of embryonic tissue for transplantation is that Statter et al [12] transplanted metanephroi, that arise
in the mouse on day 11.5 of a 20-day gestation periodfunctional APCs may be absent from the transplants
either because APCs have yet to mature in the embryos [25], originating from E14 to adult C57Bl/6 mice (H-2b)
beneath the renal capsule of adult congenic B10.A hostsor have yet to migrate into the tissue.
The first studies to address the question of APC deple- (H-2a). Expression of donor and host-specific class I
(H2Kb) and class II (Ab) transcripts in donor tissue wastion in metanephroi were performed by Foglia et al [11].
These investigators transplanted metanephroi, that origi- low at E14 and increased progressively in renal tissue
from older mice. After transplantation, surviving kidneynate in the rat on day 12.5 of a 21 day gestation period
[25], from outbred Sprague-Dawley rat embryos aged grafts showed enhanced expression of class I and class II
transcripts. However, neither class I nor class II proteinembryonic day (E)15 to E21, beneath the renal capsule
of adult Sprague-Dawley hosts. No immunosuppression could be detected in transplanted metanephroi, in con-
trast to its presence in transplanted adult renal tissue [12].was used. Under these conditions, developed kidney trans-
plants undergo acute rejection within 7 days [17]. Dekel et al [14–16] have carried out a series of investi-
gations in which human adult or embryonic kidney tissueGrowth and survival of transplants was age-dependent
in that the enlargement and differentiation in situ over is transplanted beneath the kidney capsule of immuno-
deficient rats [severe combined immunodeficiency (SCID/a 15- to 30-day period was best for metanephroi obtained
from E15 embryos and worsened progressively for renal Lewis and SCID/nude chimeric rats)]. Human adult kid-
ney fragments transplanted beneath the renal capsule ofanlagen obtained on E16 to E21. The developed E15
metanephroi showed maturation of renal elements when such rats survive for as long as 2 months posttransplanta-
tion. The overall architecture of the transplanted kidneyexamined 10 days posttransplantation and no sign of
rejection, whereas E20 metanephroi had a poor renal tissue and the normal structure of individual cells in glo-
meruli are preserved. The intraperitoneal infusion post-architecture and a dense lymphocytic infiltrate after a
comparable period of time [11]. In contrast to meta- transplantation of allogeneic human peripheral blood
mononuclear cells (PMBC) results in rejection of adultnephroi obtained on E15, liver tissue harvested on E15
and transplanted beneath the renal capsule of hosts un- human grafts [14–16].
Human fetal kidney fragments transplanted beneathderwent little growth and prompt rejection [11].
Velasco and Hegre [13] transplanted metanephroi or the renal capsule of immunodeficient rats display rapid
growth and development. Glomeruli and tubular struc-liver tissue from E15, E17, E18, or E19 inbred Fisher
rat embryos with rat major histocompatibility complex tures are maintained for as long as 4 months posttrans-
plantation. In contrast to the case for transplanted adult(RT1) RT1lvl beneath the renal capsule of RT1-incom-
patible Wistar Furth adult rats (RT1u). All fetal hepatic human kidney fragments, infusion of allogeneic human
PMBC into hosts results in either minimal human T-cellgrafts were rejected by 10 days posttransplantation. In con-
trast, the degree of rejection of the metanephroi was age- infiltration or T-cell infiltrates that do not result in rejec-
tion and do not interfere with the continued growth ofdependent, those from E15 embryos showing minimal or
moderate rejection and those from older embryos show- the human fetal renal tissue [14–16].
Fetal human grafts have reduced expression of tissueing more intense rejection. If liver and metanephroi from
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HLA classes I and II relative to the adult human grafts, that an organ could be transplanted in cellular form,
such as a metanephros, and be supplied by host vesselsconsistent with a reduced effectiveness in inducing an
alloantigen-primed T-cell response [15]. as it develops in situ [25]. Such obviation would be bene-
ficial in the case of allotransplantation. However, for
The immune response to fetal kidney transplants: xenotransplantation, it could provide a way to ameliorate
Cytokines, chemokines, and cytolytic effector molecules hyperacute rejection and acute vascular rejection that
represent two major obstacles to the use of animal kid-Dekel et al [16] have shown that transcript levels for
interferon gamma and interleukin-2 in grafts of fetal neys in humans [25].
Insight into the origin of the renal microvasculaturehuman kidneys grafted under the renal capsule of immu-
nodeficient rats are markedly reduced posttransplanta- supply is provided by experiments in which developing
kidneys are transplanted to ectopic sites. However, thetion relative to levels in adult human kidney tissue
grafted to the same site. Peak levels of these cytokines results of these experiments are somewhat contradictory.
One explanation for the differences may be that the meansappear late after PMBC infusion. Concomitant with
these findings, interleukin-4 mRNA is up-regulated dur- of vascularization is site specific. In the case of 11.5-day-
old xenograft mouse or chick metanephroi grafted ontoing the early-phase post-PMBC infusion, and interleu-
kin-10 mRNA is expressed throughout the post-PMBC the chorioallantoic membrane of the quail, the vascula-
ture is derived entirely from the host [3]. In the case ofinfusion interval. In addition, levels of mRNA coding
for chemokines regulated upon activation, normal T cell 11- to 12-day-old isograft mouse metanephroi grafted
into the anterior chamber of the eye, the glomerularexpressed and secreted (RANTES) and macrophage in-
flammatory protein-1 (MIP-1) beta, their receptor, CCR5, microvascular endothelium derives from both donor and
host [4]. In the case of E15 xenograft rat metanephroiand the cytolytic effector molecule, Fas ligand, are sup-
pressed in the fetal grafts relative to levels in adult grafts. transplanted into the peritoneal cavity of mice, the mi-
crovasculature is largely of host origin [5]. In all cases,Thus, fetal kidney induces the down-regulation of Th1
cytokines, chemokines, and fas ligand, and the sparing large external vessels derive from the host.
of Th2 cytokines in the fetal renal grafts. These findings
suggest that the human immune response of kidney rejec-
INTEGRATION OF NEW NEPHRONStion is dependent on whether the target organ is of fetal
It has been speculated that developing nephrons im-or adult origin. An allogeneic immune system appears
planted beneath the renal capsule [17] or into tunnelsto mount a T-helper 2–biased response when the target
fashioned in the cortices of host kidneys [18, 19] mightorgan is of fetal origin resulting in enhanced survival of
become incorporated into the collecting system of thetransplanted fetal tissue relative to adult tissue against
host, and thereby increase host renal function. Woolfwhich a T-helper 1–biased response is mounted [16].
et al [18, 19] implanted pieces of sectioned metanephroi
Means by which renal anlagen are vascularized originating from E13 to E16 mice into tunnels fashioned
in the cortex of kidneys of newborn outbred mice. Differ-The major arterial vessels supplying the kidney origi-
entiation and growth of donor nephrons occurred in thenate from lateral branches of the abdominal aorta [27]
host kidney. Glomeruli were vascularized, mature proxi-that terminate in a plexus of arteries in close proximity
mal tubules were formed, and extensions of metanephricto the renal pelvis, the renal artery rete [28]. It is a matter
tubules into the renal medulla were observed. However,of controversy whether the renal microvasculature (smaller
incorporation of donor nephrons into the collecting sys-vessels and glomerular capillaries) arises exclusively via
tem of hosts was not demonstrated [18, 19].this angiogenic process, or also in part from endothelial
We performed experiments similar to those of Woolfcells resident in the developing metanephros (discussed
et al, in which E15 Sprague-Dawley rat metanephroibelow). However, it is clear that during its development,
were implanted beneath the renal capsule of adult Sprague-the renal anlage is able to attract at least its major arterial
Dawley hosts. Hosts received no immunosuppression.vessels from the developing aorta [3–5, 27–29]. In that
E15 metanephroi contained segments of ureteric bud andits blood supply originates, at least in part, from outside
condensing metanephric blastema, but no glomeruli [17].of the developing renal anlage, the kidney may be re-
To determine whether subcapsularly transplanted ratgarded as a chimeric organ. Its ability to attract its own
metanephroi became integrated into host kidneys, wevasculature in situ establishes the potential for a trans-
examined kidneys of host rats 6 weeks postsubcapsularplanted metanephros to attract a vasculature from an
transplantation. To clear blood from the organ, kidneysappropriate vascular bed.
were back perfused. This results in a blanching of theHost immune responses directed against antigens lo-
kidney as blood is replaced by perfusate. Normally, thecated on the endothelium of a transplanted vascularized
entire kidney blanches. However, following perfusionorgan, such as a kidney, or mediated by transplant endo-
thelial cells would be obviated in proportion to the extent of kidneys that contained a transplanted metanephros,
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GROWING NEW KIDNEYS IN SITU
In contrast to the case for rat metanephroi trans-
planted beneath the renal capsule, metanephroi trans-
planted into a nonimmunosuppressed host rat’s fold of
omentum undergo differentiation and growth in hosts
that is not confined by a tight organ capsule [17].
A metanephros in a retroperitoneal dissection from
an E15 rat embryo is shown in Figure 2a. The ureteric
bud is delineated by an arrowhead. If transplanted with
its ureteric bud attached, the metanephros enlarges and
becomes kidney-shaped within 3 weeks (Fig. 2b). The
ureteric bud differentiates into a ureter as it would if
left in situ (Fig. 2b, arrowhead).
Metanephroi transplanted into the omentum have a
normal kidney structure and ultrastructure postdevelop-
Fig. 1. (A ) Photograph of a mid-sagittal section obtained following ment and become vascularized via arteries that originate
perfusion of a kidney originating from a rat, 6 weeks posttransplanta- from the superior mesenteric artery of hosts [25]. Figuretion. Arrows show portions of unperfused transplanted kidney. Photo-
3 shows hematoxylin and eosin (H&E)–stained sectionsmicrographs of hematoxylin and eosin (H&E)–stained kidneys. (B )
Glomerulus (g) within transplanted kidney. (C ) Glomerulus (G) within of an E15 rat metanephros (Fig. 3 a and b), with undiffer-
host kidney. Reprinted with permission [17]. entiated parenchyma consisting only of branched ure-
teric bud and metanephric blastema. Developed cortex
6 weeks postimplantation with a labeled glomerulus,
proximal tubule with a brush-border membrane (arrow-blood remained in the transplanted structure relative to
head), and distal tubule is shown in Figure 3c. A devel-the host kidney (Fig. 1A, cortex arrows). Most likely,
oped medulla with a labeled collecting duct is shown inthis reflects a reduced perfusion in chimeric blood vessels
Figure 3d. Figure 3e shows an arterial vessel that origi-(derived from transplant and host kidneys) that have
nates from the host’s omentum supplying the trans-been shown to supply transplanted metanephroi relative
planted developed metanephros.to perfusion in those supplying only the host kidney.
Developed metanephroi have a well-defined cortexBlood could be traced into the papilla of the host kidney
and medulla. Mature nephrons and collecting system(Fig. 1A, medulla, arrows). Histologic examination of
structures are indistinguishable from those of normalkidneys showed that glomeruli (g) in the transplanted
kidneys by light or electron microscopy [25].kidney (Fig. 1B) had been poorly perfused relative to
Metanephroi transplanted into the omentum surviveglomeruli present in the host kidney (Fig. 1C), in that
for as long as 32 weeks postimplantation [20], and ultra-they contained more red blood cells. Also, glomeruli in
filter inulin infused into the host’s circulation followingthe transplanted kidneys (g) were smaller than those in
ureteroureterostomy between transplant and host, a pro-the host kidney (G).
cedure that can be readily carried out if metanephroi areCollecting ducts from transplanted kidneys migrated
implanted in close proximity to the host ureter (Fig. 3f)toward the papilla of host kidneys in parallel with the
[17, 20–22, 30].vasculature [17]. However, like Woolf et al [18, 19], we
For measurement of inulin ultrafiltration, baselinewere unable to determine whether any connection be-
tween the collecting systems of donor and host kidneys measurements for inulin were performed on blood and
urine samples prior to beginning inulin infusions intowas made [17]. In addition, we found that the growth
of transplanted metanephroi was constrained by their rats. These “background” values are subtracted from
measurements performed after beginning the inulin infu-placement beneath the host kidney capsule.
The studies summarized above [17–19] show that it is sions. Infusion of inulin is initiated only following re-
moval of all native renal tissue and drainage of all urinepossible to integrate new filtering nephrons into kidneys.
If integration were accompanied by incorporation into remaining in the bladder. As a control, no ultrafiltration
of inulin can be measured in rats that have undergonethe collecting system of hosts, metanephros subrenal cap-
sular transplantation would represent a strategy for in- bilateral nephrectomy, but have no metanephros con-
nected to the bladder [17].creasing renal function. However, to be applicable to
humans with end-stage renal disease, metanephroi must If incubated with the appropriate growth factor mix
prior to implantation, ultrafiltration is enhanced andincorporate into host nephrons in end-stage kidneys that
are small and fibrotic. Such conditions are not duplicated metanephroi secrete a concentrated urine [25]. Meta-
nephroi can be preserved for 3 days prior to transplanta-by subcapsular transplantations performed thus far.
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Fig. 2. (a ) Photograph of retroperitoneal
dissection from an embryonic day (E)15 rat
embryo showing metanephros (m) and ure-
teric bud (arrowhead). (b ) Photograph of a
developed metanephros (m) in the omentum
of an adult host rat 3 weeks posttransplanta-
tion. Arrowhead shows developed ureter.
Magnification is shown. Reproduced with per-
mission [25].
Fig. 3. (a and b) Photomicrographs of hema-
toxylin and eosin (H&E)–stained midsagittal
sections of metanephroi originating from an
embryonic day (E)15 rat embryo showing a
labeled branched segment of ureteric bud (ub)
and metanephric blastema (mb). (c ) H&E–
stained section from developed metanephros
showing glomerulus (g), proximal tubule (p),
brush border (arrowhead), and distal tubule
(d). (d ) H&E–stained section of medulla from
developed metanephros showing collecting duct
(cd). (e ) Artery originating from the omentum
(a). ( f ) Anastomosis (arrow) between host
ureter and ureter from implanted metaneph-
ros (m). Magnifications are shown for (a) to
(e). Reproduced with permission [17].
tion and undergo growth differentiation and function The fact that inulin ultrafiltration can be demonstrated
in transplanted metanephroi [17, 20, 22] and survivalthat are nondistinguishable from growth, differentiation,
and function in metanephroi transplanted directly [22]. prolonged [31] indicates that that a head of pressure
sufficient to effect ultrafiltration is generated in the majorSurvival in an otherwise anephric rat (2 days) can be
prolonged to 7 days by a single transplanted developed arterial vessel (Fig. 3e) supplying transplanted meta-
nephroi. Definitive proof that such a head of pressuremetanephros [31].
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Fig. 4. Photomicrographs of stained sections
of rat metanephroi 2 weeks posttransplanta-
tion into a mouse omentum (A and B) or a rat
omentum (C and D) stained using anti-mouse
CD31. Arrowheads show positively staining
(A) and negatively staining glomeruli (C).
Arrow shows positively staining glomerular
capillary loops (B). Glomeruli (g) are labeled.
Magnifications shown in (A) are for (A) and
(C) and in (B) are for (B) and (D). Repro-
duced with permission [30].
is generated will require that survival longer than 7 days embryo into the peritoneum of 10-week-old nonimmuno-
be demonstrated. suppressed C57Bl/6J mice. Two weeks later, either no trace
Using inbred congenic rats (PVG-RT1C and PVG- of the metanephros could be found in mice, or a yellowish
RT1avl), we have shown that metanephroi can be trans- piece of tissue, too small to embed, was observed in the
planted across the RT1 locus into nonimmune-suppressed omentum. In contrast, in mice that receive costimulation
hosts [21]. A state of peripheral immune tolerance sec- blocking agents hCTLA4Ig, anti-CD45RB, and anti-
ondary to T cell “ignorance” permits the survival of CD154, the transplanted rat metanephros undergoes dif-
transplanted metanephroi. Most likely the “ignorance” ferentiation and growth in situ [5].
results from the absence of APCs originating from the To gain insight into the origin of the vasculature (do-
donor in the embryonic renal tissue, and the consequent nor versus host) of metanephroi transplanted in the
absence of direct presentation of transplant antigen to omentum, using our rat to mouse model, we stained
host T cells (presentation by donor dendritic cells to host developing rat metanephroi using mouse specific anti-
T cells) as was shown previously for subrenal capsular
bodies directed against the endothelial antigen CD31 [5].
transplants [11].
Shown in Figure 4 are photomicrographs of a paraffin-As for rats [17, 20–22] allotransplantation of meta-
embedded section containing developed glomeruli (g)nephroi from outbred Yucatan miniature pig embryos
in a Lewis rat metanephros following 2 weeks of trans-to adult outbred Yucatan miniature pigs can be carried
plantation into a C57Bl/6J mouse (Fig. 4 A and B) or aout without host immunosuppression [24]. On E28 (pre-
Lewis rat (Fig. 4 C and D), stained using antimouseimplantation), the Yucatan minipig metanephros consists
CD31. Positively staining glomeruli (rat to mouse) areof undifferentiated metanephric blastema and branched
shown in Figure 4A. Negatively stained glomeruli (ratureteric bud. Two weeks posttransplantation into the
to rat) are shown in Figure 4C (arrowheads). The vascu-omentum of an adult host, Yucatan minipig metanephroi
lature of the transplanted developed rat kidney trans-are enlarged and have the characteristic lobular pig kid-
planted into the mouse is largely of mouse origin, includ-ney-like structure [24].
We transplanted metanephroi from an E15 Lewis rat ing glomerular capillary loops (Fig. 4B). In contrast,
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Fig. 5. Photographs (A and B ) and hematoxylin and eosin (H&E)-stained sections (C and D ) of pig metanephroi 21 days posttransplantation
into mice. (A) A pig metanephros (pm) in a mouse omentum. (u) ureter. (B) A pig metanephros (pm) and native mouse (mk) kidney are shown
after removal from the mouse host. (C) The nephrogenic zone is delineated (open arrows). Glomeruli (g) and a collecting duct (closed arrows)
are labeled. (D) The boundary of the nephrogenic zone (nz) is delineated (arrows). A glomerulus is labeled (g). Magnifications are shown.
Reproduced with permission [24].
glomerular capillary loops in rat metanephroi trans- are present in the cortex as is a branched collecting duct
(cd). Figures 5D is a higher power view. The boundaryplanted into rats do not stain for mouse CD31 (Fig. 4D).
The data shown in Figure 4 are consistent with a host of the nephrogenic zone is delineated in Figure 5D
(arrows). A developing nephron within the nephrogenicorigin for much of the vasculature that develops subse-
quent to transplantation of metanephroi into an intra- zone (nz) and glomerulus (g) are labeled.
Dekel et al [23] implanted metanephroi from E70 hu-peritoneal site, including glomerular capillary loops. In
that much of its vasculature originates from the host, the man embryos intraperitoneally into NOD/SCID mice.
Transplanted kidneys survived for more than 2 monthstransplanted developed metanephros may be regarded
as a chimeric organ [17]. posttransplantation, became vascularized, and differenti-
ated into normal-appearing tubules and glomeruli.We transplanted E28 Yorkshire pig metanephroi into
the peritoneum of Lewis rats [30] or C57Bl/6J mice [24] Hybridization to cDNA arrays of RNA derived from
normal human renal anlage at 8, 12, 16, or 20 weeks ofthat received co-stimulatory blocking agents. As was the
case for rat to mouse xenografts [5], no growth or devel- gestation demonstrated a subset of 240 genes the expres-
sions of which changed substantially with time. The in-opment of pig metanephroi is observed in the absence
of host co-stimulatory blockade. In contrast, Figure 5A duced genes were classified as cell cycle regulators; tran-
scription and growth factors; and signaling, transport,shows a Yorkshire pig metanephros (pm) 21 days post-
implantation into the omentum of a C57Bl/6J mouse adhesion, and extracellular matrix molecules. Clustering
analysis of global gene expression in transplants at 2, 6,that was treated with co-stimulatory blockade. Figure
5B shows the pig metanephros and native mouse kidney and 10 weeks posttransplantation revealed a temporal
profile of gene expression similar to that which was ob-after removal from the mouse. H&E-stained sections of
paraffin-embedded metanephroi are shown in Figures 5 C served in the normal human kidneys during develop-
ment, consistent with recapitulation of a renal develop-and D. Figure 5C delineates the nephrogenic zone in
which nephron formation is ongoing in the outer cortex mental program [23]. Comparison of the expression
profiles of developing metanephric transplants to a Wilms’(arrows) and more-differentiated cortex. Glomeruli (g)
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tumor specimen revealed no similarity. It was concluded bovine fibroblasts. They transplanted subcutaneously into
an adult bovine host cultured dispersed kidney cells from itsthat there is no threat of malignant transformation after
transplantation of human kidney precursors [23]. E56 cloned embryo, seeded on collagen-coated cylindrical
polycarbonate membranes. Cloned and passaged kidney
cells expressed renal specific proteins in vitro, including
USE OF STEM CELLS synaptopodin, aquaporin-1, aquaporin-2, and Tamm-Hors-
For some clinical applications of tissue engineering, fall protein. After expansion, the cells produced, in addi-
embryonic stem (ES) cells may represent a useful start- tion, both 1,25(OH)D3 and erythropoetin [36].
ing material [32]. A possible example is provided by Straw-colored fluid was produced by “renal units” that
studies of neuron repopulation. Mouse ES cells exposed had differentiated in situ into glomerulus-like and tu-
to retinoic acid are induced to express neural-associated bule-like structures and had undergone vascularization.
genes, exhibit neurite outgrowth, and can generate action Chemical analysis of collected fluid suggested unidirec-
potentials [33]. Neural-differentiated mouse ES cells tional secretion and concentration of urea nitrogen and
transplanted into a rat spinal cord 9 days after injury creatinine. Cells within “renal units” produced synapto-
survive, differentiate into astrocytes, oligodendrocytes, podin, aquaporin-1, aquaporin-2, and Tamm-Horsfall
and neurons, and migrate from the edge of the lesion. protein. No rejection response was detected in hosts to
Hind limbs of transplanted rats are able to support the cloned renal cells [36].
weight and exhibit partial coordination not found in hind
limbs of control animals [34].
BIOENGINEERING OF AN ARTIFICIAL KIDNEYFor other clinical applications, the use of ES cells as
starting material may be more problematic than in neu- Hemodialysis replaces some filtration functions of the
kidney, but does not recapitulate endocrine/metabolicron repopulation. One such application is the replacement
of kidneys. activities of renal cells. To address this deficiency, Humes
et al have developed a synthetic hemofiltration cartridgeWith the exception of its nerve supply, the kidney is
a mesodermal derivative. Therefore, it is conceivable and a renal tubule cell-assist device (RAD) containing
porcine [37] or human [38] cells in an extracorporealthat each of its original cell types, plus the ureteric bud,
could originate from a renal-specific descendent of a single circuit. The RAD replaces both renal filtration and endo-
crine/metabolic activity. Cells are grown as confluentES cell. Al Awqati and Oliver [1] have speculated that,
if it is present at all, such a precursor might be located monolayers along the inner surface of hollow fibers within
a standard hemofiltration cartridge. The nonbiodegrad-somewhere within the intermediate mesoderm at a given
stage of embryogenesis. ability and the pore size of the hollow fibers permit the
membranes to act as both scaffolds for the cells andOliver et al [35] have shown that cultures of metaneph-
ric blastema can generate not only renal epithelial cells, as an immunoprotective barrier. The isolated/expanded
renal cells show differentiated renal transport, metabolic,but also cells that are positive for -smooth muscle actin
(-SMA), indicating that they are myofibroblast precur- and endocrine activity [37, 38].
The RAD placed in series to a standard hollow fibersors, as well as cells that express receptors for vascular
endothelial growth factor, consistent with an endothelial hemofiltration cartridge with untrafiltrate and postfil-
tered blood connections can reproduce functional rela-lineage. Their observations suggest that the metanephric
blastema contains embryonic renal stem cells [35]. tionship between the glomerulus and tubule. Its use in
the treatment of acutely uremic dogs increases excretionIf renal precursor cells exist and can be identified, it
might be possible to coax the cells to divide, and to of ammonia and enhances glutathione metabolism and
1,25(OH)2D3 production during 24 hours of treatment.have the progenitors organize themselves into a kidney.
However, to accomplish such a feat, an orchestration of The evaluation of this device in the treatment of severely
ill patients with acute renal failure has been initiated [38].gene expression would need to be externally imposed
that almost certainly would be far more complex than
that required to coax ES cells to develop into a single
CONCLUSIONcell type or even multiple related cell types such as neu-
End-stage chronic renal failure afflicts more thanrons and glia [1, 32–34].
300,000 individuals in the United States. Most of these
people receive (1) dialysis, a treatment that, although
GENERATION OF HISTOCOMPATIBLE TISSUES life-preserving, replaces only a small fraction of normal
USING NUCLEAR TRANSPLANTATION kidney function and has considerable morbidity, or (2)
(THERAPEUTIC CLONING) renal allotransplantation, which is limited by the number
of human organs available. One possible solution to theLanza et al [36] have created bioengineered tissues
from cardiac, skeletal, and renal cells cloned from adult lack of organ availability is the use of renal xenografts.
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However, the results of xenografting of kidneys have mans of organs from other species such as pigs which in
many other ways represent an ideal kidney donor forbeen unsatisfactory, and this technique has remained an
experimental one [25]. humans [39].
The clinical applicability for xenotransplantation ofThere is a potential role for tissue engineering in the
replacement of renal function. Such a role could be ful- pig metanephroi into humans as a means to increase
renal function will require that several challenges be met:filled through the engineering, in its entirety, of a new
renal organ. However, at least in the short term, the role (1) a level of renal function in transplants sufficient to
sustain life will need to be attained; (2) an optimal xeno-of tissue engineering will probably be as an adjunct to
transplantation or dialysis technologies. graft donor will need to be identified, perhaps -gal–
deficient animals [39], and co-stimulatory blocking orFive approaches toward tissue engineering of a kidney
have been reviewed herein. Only one, the bioengineered immunosuppression protocols established; (3) the risk
of pathogen transmission from donor to host (includingartificial kidney [37, 38] is currently being evaluated in
patients, and then only for short-term use in the setting retroviruses) will need to be minimized; and (4) long-
term life-sustaining function of transplanted developedof severe acute renal failure.
In terms of their incorporation into a tissue-engi- metanephroi will need to be demonstrated in a pig to
primate model.neered organ to replace renal function long-term, endo-
crine/metabolic functions kidneys are probably less im- The development of tissue engineering technologies
for replacement of kidney function will take time. Toportant than filtration reabsorption and secretion. Active
forms vitamin D and erythropoetin, routinely adminis- understand that this is the case, one need only contem-
plate the chronology of events that led to the implemen-tered to patients with end-stage renal failure, can correct
endocrine deficiencies resulting from loss of functional tation of hemodialysis as summarized by Peter Morrin
[40]. The first successful dialysis of animals was carriedrenal tissue. However, in the setting of acute renal fail-
ure, replacement of endocrine/metabolic functions could out in 1903, and the first human dialysis was performed in
1926. During the ensuring 30 years, a number of differentprovide the difference between survival and death [37, 38].
The feasibility of integrating new nephrons into a dis- experimental approaches to hemodialysis of humans
were employed [40]. Yet, reflecting in 1994 on the firsteased kidney using existing approaches is probably quite
low. Even if a way were found to connect the new neph- year of his nephrology training at Washington University
in 1958, Morrin notes, “The common problems of ne-ron units to the host’s collecting system, the diseased
and fibrotic state of the host kidney would limit the utility phrology were essentially the same as they are today,
but our knowledge of the underlying pathophysiologyof this technique.
For reasons outlined above, the use of ES cells to grow and our ability to deal with them were significantly less.
Dialysis for acute renal failure was considered an experi-a kidney appears to be a technology that will not soon
come to fruition. However, the feasibility for use of nu- mental therapy and limited to a few centers with special
interests in the area. There was no effective treatmentclear transfer–generated cells and tissue as transplants has
been demonstrated in a large animal model, the cow [36]. for chronic renal failure [40].”
The successful implementation of hemodialysis re-While such a strategy could not be employed in humans,
as ethical considerations require that preimplantation quired parallel advances in antigcoagulation therapy, ar-
tificial membrane technology and the development ofembryos not be developed in vitro beyond the blastocyst
stage, these findings may be applicable to engineered vascular access [40]. Any accounting for the progress to
date in tissue engineering the kidney must consider thatadult native cells or human ES cells [36].
The intraperitoneal transplantation of intact organ we are 100 years into hemodialysis, but only one or two
decades into renal tissue engineering. The latter, like theprecursors “preprogrammed” to differentiate into a kid-
ney and attract a vasculature (metanephroi) has been former, will be impacted upon by advances in related
technologies. There will be more renal tissue engineeringemployed toward the goal of “growing” a kidney. At
least in some settings, direct presentation of transplant to come.
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